StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Avenue Therapeutics's pe ratio was 0.1× on Jan 30, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 20260.1×−0.2
2025Dec 31, 20250.2×–

More Avenue Therapeutics figures

See a number that looks wrong?